Advisory Council for the Elimination of Tuberculosis: Notice of Charter Renewal., 15697 [E7-6016]
Download as PDF
Federal Register / Vol. 72, No. 62 / Monday, April 2, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the charter
for the Interagency Committee on
Smoking and Health (ICSH) of the
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services, has been renewed
for a 2-year period through March 20,
2009.
For further information, contact Dana
Shelton, Executive Secretary,
Interagency Committee on Smoking and
Health, Centers for Disease Control
Prevention, of the Department of Health
and Human Services, CDC, 4770 Buford
Highway, NE., M/S K–50, Atlanta,
Georgia 30341–3717, telephone 770–
488–5709 or fax 770–488–5767.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
hsrobinson on PROD1PC76 with NOTICES
Advisory Council for the Elimination of
Tuberculosis: Notice of Charter
Renewal.
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Council for the Elimination of
Tuberculosis, Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
March 15, 2009.
For information, contact Kenneth
Castro, M.D., Executive Secretary,
Advisory Council for the Elimination of
Tuberculosis, Centers for Disease
18:39 Mar 30, 2007
Jkt 211001
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. E7–6016 Filed 3–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Peer Review of
Division of HIV/AIDS Prevention
Intramural International Biomedical
Interventional Research in Thailand,
Kenya, Botswana and Cameroon
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. E7–6020 Filed 3–30–07; 8:45 am]
VerDate Aug<31>2005
Control and Prevention, Department of
Health and Human Services, 1600
Clifton Road, NE., Mailstop E10,
Atlanta, Georgia 30333, telephone 404/
639–8000 or fax 404/639–8604.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Times and Dates: 8 a.m.–5 p.m., May 2,
2007 (Closed) 8 a.m.–5 p.m., May 3, 2007
(Closed).
Place: Corporate Square, 9 Corporate
Boulevard, Suite 100, Atlanta, GA 30329,
telephone 404–679–7900.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of the ‘‘Division of HIV/AIDS
Prevention Intramural International
Biomedical Interventional Research in
Thailand, Kenya, Botswana and Cameroon.’’
Contact Person for More Information: Elise
M. Beltrami, M.D., M.P.H., Designated
Federal Official, National Center for
Preparedness, Detection and Control of
Infectious Diseases, Division of Healthcare
Quality Promotion, CDC, 1600 Clifton Road
N.E., Mailstop A–31, Atlanta, GA 30333,
Telephone 404–639–4271.
The Director, Management Analysis and
Services Office, has been delegated the
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
15697
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6009 Filed 3–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Provider and
Public Health Input for Vaccine Policy
Decisions, Potential Extramural Project
(PEP), 2007–R–04
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–4 p.m., May 8,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to PEP 2007–R–04, ‘‘Provider and
Public Health Input for Vaccine Policy
Decisions.’’
Contact Person for More Information:
Christine J. Morrison, PhD Scientific Review
Administrator, Office of the Chief Science
Officer, CDC, 1600 Clifton Road NE, Mailstop
D–72, Atlanta, GA 30333, Telephone
(404)639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6010 Filed 3–30–07; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\02APN1.SGM
02APN1
Agencies
[Federal Register Volume 72, Number 62 (Monday, April 2, 2007)]
[Notices]
[Page 15697]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis: Notice of
Charter Renewal.
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Advisory Council for the
Elimination of Tuberculosis, Centers for Disease Control and
Prevention, Department of Health and Human Services, has been renewed
for a 2-year period through March 15, 2009.
For information, contact Kenneth Castro, M.D., Executive Secretary,
Advisory Council for the Elimination of Tuberculosis, Centers for
Disease Control and Prevention, Department of Health and Human
Services, 1600 Clifton Road, NE., Mailstop E10, Atlanta, Georgia 30333,
telephone 404/639-8000 or fax 404/639-8604.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. E7-6016 Filed 3-30-07; 8:45 am]
BILLING CODE 4163-18-P